Autoimmune Diseases  >>  Lemtrada (alemtuzumab)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lemtrada (alemtuzumab) / Sanofi
CARE MS I and MS II, NCT01020370: Exploratory Study to Investigate the Reparative and Regenerative Potential of Alemtuzumab in Relapsing-Remitting Multiple Sclerosis Patients Participating in the Studies

Completed
N/A
US
Wayne State University
Multiple Sclerosis
 
 

Download Options